Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

pembrolizumab 3Nivolumab 3Valganciclovir 2Filgrastim 2Etoposide 2Docetaxel 2valspodar 1talimogene laherparepvec 1liposomal doxorubicin 1lenvatinib 1fialuridine 1etoposide phosphate 1efineptakin alfa 1X-Rays 1Thalidomide 1Sunitinib 1Specimen Handling 1SUB1 protein, human 1Ritonavir 1Propranolol 1Peripheral Blood Stem Cell Transplantation 1Nevirapine 1Nelfinavir 1Maraviroc 1Magnetic Resonance Spectroscopy 1Lopinavir 1Indinavir 1Ifosfamide 1Gemcitabine 1Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Kaposi × fialuridine × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡